Susquehanna International Group, LLP Harrow Health, Inc. Call Options Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

Call Options

20 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$20.85 - $46.47 $135,525 - $302,055	6,500 Added 1.31%	500,900 $22.5 Million
Q2 2024 Aug 15, 2024	BUY	$10.0 - $21.64 $4.49 Million - $9.71 Million	448,500 Added 977.12%	494,400 $10.3 Million
Q1 2024 May 07, 2024	SELL	$9.3 - $13.23 $57,660 - $82,026	-6,200 Reduced 11.9%	45,900 $607,000
Q4 2023 Feb 14, 2024	BUY	$8.1 - $16.36 $242,190 - $489,164	29,900 Added 134.68%	52,100 $583,000
Q3 2023 Nov 14, 2023	SELL	$14.03 - $22.08 $200,629 - $315,744	-14,300 Reduced 39.18%	22,200 $319,000
Q2 2023 Aug 11, 2023	SELL	$17.37 - $28.08 $90,324 - $146,016	-5,200 Reduced 12.47%	36,500 $694,000
Q1 2023 May 16, 2023	SELL	$13.84 - $21.46 $799,952 - $1.24 Million	-57,800 Reduced 58.09%	41,700 $882,000
Q4 2022 Feb 14, 2023	BUY	$10.28 - $14.78 $169,620 - $243,870	16,500 Added 19.88%	99,500 $1.47 Million
Q3 2022 Nov 14, 2022	BUY	$6.57 - $24.88 $545,310 - $2.07 Million	83,000 New	83,000 $1 Million
Q1 2022 May 16, 2022	SELL	$6.77 - $8.66 $13,540 - $17,320	-2,000 Reduced 13.61%	12,700 $87,000
Q4 2021 Feb 14, 2022	SELL	$8.5 - $12.0 $45,900 - $64,800	-5,400 Reduced 26.87%	14,700 $127,000
Q3 2021 Nov 15, 2021	SELL	$6.99 - $10.6 $54,522 - $82,680	-7,800 Reduced 27.96%	20,100 $183,000
Q2 2021 Aug 11, 2021	SELL	$6.68 - $11.07 $30,060 - $49,815	-4,500 Reduced 13.89%	27,900 $259,000
Q1 2021 May 17, 2021	SELL	$6.26 - $11.03 $517,702 - $912,181	-82,700 Reduced 71.85%	32,400 $219,000
Q4 2020 Feb 16, 2021	BUY	$4.76 - $6.93 $3,808 - $5,544	800 Added 0.7%	115,100 $790,000
Q3 2020 Nov 16, 2020	BUY	$4.71 - $7.36 $448,863 - $701,408	95,300 Added 501.58%	114,300 $639,000
Q2 2020 Aug 14, 2020	SELL	$3.61 - $6.47 $280,497 - $502,719	-77,700 Reduced 80.35%	19,000 $99,000
Q4 2019 Feb 14, 2020	BUY	$4.6 - $7.88 $250,699 - $429,460	54,500 Added 129.15%	96,700 $752,000
Q3 2019 Nov 14, 2019	BUY	$4.89 - $8.0 $55,257 - $90,400	11,300 Added 36.57%	42,200 $237,000
Q2 2019 Aug 14, 2019	BUY	$4.2 - $8.7 $129,780 - $268,830	30,900 New	30,900 $269,000

Others Institutions Holding HROW

# of Institutions

176

Shares Held

21.4M

Call Options Held

845K

Put Options Held

717K

Opaleye Management Inc. Boston, MA

3.99M
Shares

$156 Million
32.75% of portfolio
Private Capital Management, LLC Naples, FL

2.16M
Shares

$84.4 Million
11.41% of portfolio
Black Rock Inc. New York, NY

2.15M
Shares

$83.8 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

1.87M
Shares

$72.8 Million
0.0% of portfolio
State Street Corp Boston, MA

731K
Shares

$28.5 Million
0.0% of portfolio

View Full List

About HARROW HEALTH, INC.

Ticker HROW
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 27,070,000
Market Cap $1.06B
Description
Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...

More about HROW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account